The Wearable Pump master contract with Sanofi excluded Diabetics.
Medtronics has been dropped from the Google Sanofi DexCom collaboration in regard to Diabetic.
UNIS was not immediately announced as a replacement, but clearly has outstanding technology in the Imperium.
Medtronics is currently at the forefront of Diabetic Pump injection and has spent vasts amounts of money testing their products and developing the associated electronic monitoring attachments and Wi Fi programs.
Medtronics has alliances already with Google, Sanofi and DotCom.
Dean Kamen is rich and is the inventor of the first Diabetic Pump and has associations with Medtronics and other people at the highest Network levels.
AS stated that someone wanted to buy the Wearable Pumps patents from UNIS years ago, but didn't like the value AS attached to it.
I think that Medtronics business is largely invested in Diabetics Pumps, the artificial Panceous and the have heaps of money.
I think these dots connect to a very high UNIS SP.
I think 2016 will be a very good year
I bought some more yesterday.
All IMO
